Acasă › Cancer pulmonar cu celule non-pătrate › Indiana › Fort Wayne
Studii clinice pentru Cancer pulmonar cu celule non-pătrate în Fort Wayne, IN
17 studii pentru Cancer pulmonar cu celule non-pătrate caută participanți în și în jurul orașului Fort Wayne (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
A Study to Assess Adverse Events and Change in Disease Activity of Intravenous (IV) Telisotuzumab Adizutecan, Monotherapy or in Combination With Osimertinib, Compared to Standard of Care in Adult Participants With Locally Advanced or Metastatic EGFR-Mutated Non-Squamous Non-Small Cell Lung Cancer
În curs de recrutareFaza 2/3
- Parkview Research Center /ID# 277651, Fort Wayne
Study to Evaluate Adverse Events and Efficacy of Intravenous (IV) Telisotuzumab Adizutecan in Combination With a PD-1 Immune Checkpoint Inhibitor in Adult Participants With Advanced or Metastatic Non-Squamous NSCLC With No Prior Treatment for Advanced Disease, and No Actionable Genomic Alterations
În curs de recrutareFaza 1/2
- Parkview Comprehensive Cancer Center /ID# 271879, Fort Wayne
Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO])
În curs de recrutareFaza 3
- Parkview Regional Medical Center, Fort Wayne
A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)
În curs de recrutareFaza 3
- Fort Wayne Medical Oncology and Hematology, Fort Wayne
A Study to Assess Efficacy and Safety of Pembrolizumab With or Without Sacituzumab Tirumotecan (MK- 2870) in Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019)
În curs de recrutareFaza 3
- Parkview Research Center at Parkview Regional Medical Center ( Site 0089), Fort Wayne
A Study of Amivantamab in Combination With Lazertinib, or Amivantamab in Combination With Platinum-Based Chemotherapy, for Common Epidermal Growth Factor Receptor (EGFR)-Mutated Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC)
În curs de recrutareFaza 2
- Fort Wayne Medical Oncology and Hematology, Fort Wayne
Study of Olomorasib (LY3537982) in Combination With Standard of Care in Participants With Resected or Unresectable KRAS G12C-mutant Non-Small Cell Lung Cancer
În curs de recrutareFaza 3
- Parkview Research Center at Parkview Regional Medical Center, Fort Wayne
A Study of Adagrasib Plus Pembrolizumab Plus Chemotherapy vs. Placebo Plus Pembrolizumab Plus Chemotherapy in Participants With Previously Untreated Non-squamous Non-small Cell Lung Cancer With KRAS G12C Mutation (KRYSTAL-4)
În curs de recrutareFaza 3
- Parkview Research Center at Parkview Regional Medical Center, Fort Wayne
Safety, Efficacy, and Pharmacokinetics of BNT327 in Combination With Chemotherapy and Other Investigational Agents for Lung Cancer
În curs de recrutareFaza 2/3
- Fort Wayne Medical Oncology and Hematology, Inc., Fort Wayne
A Global Phase III Study of Rilvegostomig or Pembrolizumab Plus Chemotherapy for First-Line Treatment of Locally Advanced or Metastatic Squamous Non-small Cell Lung Cancer (NSCLC)
În curs de recrutareFaza 3
- Research Site, Fort Wayne
A Study of First-Line Olomorasib (LY3537982) and Pembrolizumab With or Without Chemotherapy in Patients With Advanced KRAS G12C-Mutant Non-small Cell Lung Cancer
În curs de recrutareFaza 3
- Parkview Research Center at Parkview Regional Medical Center, Fort Wayne
Phase III, Open-label Study of First-line Osimertinib With or Without Datopotamab Deruxtecan for EGFRm Locally Advanced or Metastatic Non-small Cell Lung Cancer
În curs de recrutareFaza 3
- Research Site, Fort Wayne
A Phase 1 of CTX-8371 in Patients With Advanced Malignancies
În curs de recrutareFaza 1
- Fort Wayne Medical Oncology and Hematology, Fort Wayne
A Study of Sigvotatug Vedotin in Advanced Solid Tumors
În curs de recrutareFaza 1
- Fort Wayne Medical Oncology and Hematology, Inc, Fort Wayne
LUNAR-2: TTFields With Pembrolizumab + Platinum-based Chemotherapy for Metastatic NSCLC
În curs de recrutareFaza 3
- Parkview Packnett Family Cancer Institute, Fort Wayne
Study to Assess Adverse Events and Pharmacokinetics in Adult Participants With Non-Small Cell Lung Cancer, Head and Neck Squamous Cell Carcinoma and Other Solid Tumors, Receiving Intravenous Infusion of Azirkitug Alone or in Combination(s) With Budigalimab, Bevacizumab, or Telisotuzumab Adizutecan
În curs de recrutareFaza 1
- Fort Wayne Medical Oncology and Hematology, Inc /ID# 232593, Fort Wayne
BostonGene and Exigent Genomic INsight Study
În curs de recrutareStudiu observațional
- Fort Wayne Medical Oncology and Hematology, Fort Wayne
Studii pentru Cancer pulmonar cu celule non-pătrate în alte orașe
- Houston, TX145 studii
- New York City, NY121 studii
- Arlington, VA104 studii
- Nashville, TN97 studii
- Boston, MA90 studii
- Los Angeles, CA87 studii
- St. Louis, MO73 studii
- Chicago, IL61 studii
- Baltimore, MD60 studii
- San Antonio, TX59 studii
- Columbus, OH57 studii
- Washington, DC55 studii
Alte studii în Fort Wayne
- Cancer ovarian8 studii
- Cancer (toate tipurile)7 studii
- Leucemie limfatică cronică7 studii
- Cancer de sân7 studii
- Cancer pulmonar6 studii
- Cancer metastatic6 studii
- Cancer endometrial5 studii
- Melanom4 studii
- Carcinom cu celule scuamoase de cap și gât4 studii
- Cancer de sân triplu negativ4 studii
- Cancer colorectal4 studii
- Mielom multiplu4 studii
Sursă: ClinicalTrials.gov, date preluate la 6 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.